AXL and neoplasm: Irrespective of downstream signaling, shRNA-mediated AXL knockdown significantly diminished the tumor-forming capacities of Lipo-246 and Lipo-863 cells in vivo, a finding that indicates that AXL may represent a molecular target in a subset of DDLPS tumors.